Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ma-Spore ALL-Seq 2020
NCT06336395Phase 2Recruiting
- Sponsor
- National University Hospital
- Start
- Mar 2020
- Primary completion
- Mar 2030
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of GAMMA regimen in B cell acute lymphoblastic leukemia (B-ALL), sponsored by National University Hospital. Started Mar 2020; status: recruiting.
02
Drugs
GAMMA regimen
03
Conditions
B cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT06336395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06336395.